CAR-T Cell Therapy for Solid Tumors
Background: Chimeric antigen receptor (CAR)-modified T cells have shown remarkable results for the treatment of selected hematological malignancies, but recapitulating these results in solid cancers has been a major challenge. In this review, we discuss lessons learned from recent clinica...
Saved in:
| Main Authors: | Liz T. Tony, Andrea Stabile, Marc P. Schauer, Michael Hudecek, Justus Weber |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Transfusion Medicine and Hemotherapy |
| Online Access: | https://karger.com/article/doi/10.1159/000542438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision sniper for solid tumors: CAR-NK cell therapy
by: Sisi Li, et al.
Published: (2025-07-01) -
CAR T cell therapy for central nervous system solid tumors: current progress and future directions
by: Yaroslav Kaminskiy, et al.
Published: (2025-08-01) -
Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review
by: Ahsen Morva, et al.
Published: (2025-06-01) -
Advancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions
by: Jiajun Zhu, et al.
Published: (2025-08-01) -
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
by: Alejandro G. Torres Chavez, et al.
Published: (2025-07-01)